— Know what they know.
Not Investment Advice

GENO.ST STO

Genovis AB
1W: +3.0% 1M: -9.1% 3M: +1.8% YTD: -0.4% 1Y: -19.8% 3Y: -55.9% 5Y: -65.0%
kr 19.54 ($1.95)
-0.14 (-0.71%)
 
Weekly Expected Move ±4.8%
kr 18 kr 19 kr 20 kr 20 kr 21
STO · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · kr 1.3B mcap · 57M float · 0.189% daily turnover

📊 Key Metrics

TTM
kr 136M
Revenue
+11.2% YoY
kr 20M
Net Income
-24.0% YoY
kr 32M
Free Cash Flow
+7.5% YoY
90.2%
Gross Margin
8.2%
Op. Margin
3.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE7.5%
ROA5.4%
ROIC7.1%

Valuation

P/E65.1
P/B4.2
EV/EBITDA35.3

Leverage

Debt/Equity0.26
Current Ratio5.76
Interest Cov.30.4x

Quality Scores

Piotroski F4/9
Altman Z7.51
Beneish M-1.78

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms